@misc{indiciae8be06cd32ed7,
  title = {CD8 T-cell dysfunction is linked with CAR T-cell failure and can be mitigated by a non-alpha IL-2 agonist, pegenzileukin},
  author = {Reville, P. K. and Sheikh, I. N. and Choi, A. and Dai, E. and Henderson, J. and Li, X. and Rojas, E. and Le, C. C. and Okwuchi, C. and Devonish, M. and Carrio, R. and Pate, N. and Malley, K. and Bangari, D. and Givigan, J.-A. and Shi, C. and Liu, B. and Byers, T. and Westin, J. and Ahmed, S. and Fowler, N. and Fayad, L. and Lee, H. J. and Nastoupil, L. and Sassoon, I. and Cucchetti, M. and Wang, R. and Agarwal, M. and Abbadessa, G. and Meng, R. and Meibalan, E. and Powers, L. and Cao, J. and Ying, X. and Balko, K. and Yu, Q. and Jiao, J. and Cortez-Retamozo, V. and Sidhu, S. and Shaffer, D. and Neelapu, S. and Wang, L. and Green, M. R.},
  year = {2023},
  doi = {10.1101/2023.08.28.555127},
  url = {https://www.biorxiv.org/content/10.1101/2023.08.28.555127v1},
  note = {Source identifier: 10.1101/2023.08.28.555127}
}